As a result, unlike NEDD4-1 or WWP2, FBXO22 did not affect AKT activation, but negatively regulated nuclear PTEN functions, such as the activity of APC/C-CDH1 complex and alternative splicing, to play a tumor-promoting role. The gene discussed is PTEN; the disease is neoplasm.